Sfoglia per Autore
HCV genotype and serum 90K levels: host and virus related factors predict response to a-ifn therapy
1995-01-01 Natoli, G; Tinari, Nicola; D'Egidio, Maurizia; Angelucci, Domenico; Artini, Marco; Costanzo, Antonio; Marinelli, Rossana; Balsano, Clara; Levrero, Massimo; Iacobelli, Stefano; Natoli, Clara
The 90K tumor associated antigen and clinical progression in human immunodeficiency virus infection
1995-01-01 Iacobelli, Stefano; Ullrich, A; Tinari, Nicola; Ortona, L; Tamburrini, E; D'Egidio, Maurizia; Ghinelli, F; Sighinolfi, L; Piazza, M; Chirianni, A; Guerra, L; Natoli, Clara
A Flow cytometric study of early gastric cancer
1996-01-01 Ranaldi, R; Santinelli, A; Fabris, G; Mannello, B; Natoli, Clara; Tinari, Nicola; Bearzi, I.
Prognostic value of a novel interferon-inducible 90K tumor antigen
1996-01-01 D'Ostilio, N; Natoli, Clara; Grassadonia, Antonino; Rossi, N; DI STEFANO, P; Amatetti, C; Tinari, Nicola; Iacobelli, S.
Prognostic value of a novel interferon-inducible 90K tumor antigen
1996-01-01 D'Ostilio, N; Natoli, Clara; Grassadonia, Antonino; Rossi, N; Di Stefano, P; Amatetti, C; Tinari, Nicola; Iacobelli, Stefano
Elevated serum levels of 90K/MAC-2BP predict unresponsiveness to alfa-interferon therapy in chronic HCV hepatitis patients
1996-01-01 Artini, M; Natoli, Clara; Tinari, Nicola; Costanzo, A; Marinelli, R; Balsano, C; Porcari, P; Angelucci, D; D'Egidio, Maurizia; Levrero, M; Iacobelli, Stefano
Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90k monoclonal antibodies
1997-01-01 Tinari, Nicola; D'Egidio, Maurizia; Starling, Gary; Seachord, Carrie; Darveau, Richard; Aruffo, Alejandro; Bowen, Michael; Iacobelli, Stefano
A PHASE II STUDY OF NEOADJUVANT CHEMOTHERAPY WITH CISTAPLIN, EPIRUBICIN AND VP – 16 FOR STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER
1998-01-01 Iacobelli, Stefano; L., Irtelli; Sacco, Rocco; T., Martino; Mascitelli, Elia; L., Basilico; M. T., Scognamiglio; Natoli, Clara; O., Fusco; Tinari, Nicola; V., Beltrami
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10^6 cells/L
1998-01-01 Tinari, Nicola; Natoli, Clara; D'Ostilio, N.; Ghinell, F.; Sighinolfi, L.
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections
1999-01-01 Fornarini, B.; Iacobelli, Stefano; Tinari, Nicola; Natoli, Clara; DE MARTINO, M.
Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo.
2000-01-01 B., Fornarini; C., D’Ambrosio; Natoli, Clara; Tinari, Nicola; Iacobelli, Stefano
galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis
2000-01-01 Matarrese, P; Tinari, Nicola; Semeraro, Ml; Natoli, Clara; Iacobelli, Stefano; Malorni, W.
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
2000-01-01 Natoli, Clara; Scognamiglio, M. T.; Martino, M. T.; Irtelli, L.; DE TURSI, Michele; Cianchetti, Ettore; Mascitelli, Elia; Tinari, Nicola; Iacobelli, Stefano
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties
2000-01-01 Matarrese, P.; Fusco, O.; Tinari, Nicola; Natoli, Clara; Liu, F. T.; Semeraro, Ml; Malorni, W; Iacobelli, Stefano
Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients
2000-01-01 Iurisci, Ida; Tinari, Nicola; Natoli, Clara; Angelucci, D.; Cianchetti, Ettore; Iacobelli, Stefano
Gli analoghi sintetici delle glicoamine come potenziali nuovi farmaci nella prevenzione delle metastasi
2001-01-01 Innominato, Pf; Natoli, Clara; Tinari, Nicola; Piccolo, E; Grassadonia, Antonino; Iurisci, I; Cumashi, A; Iacobelli, S.
Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly
2001-01-01 Iacobelli, Stefano; Irtelli, L; Martino, Mt; Natoli, Clara; Tinari, Nicola; Grassadonia, Antonino; Rocco, Sacco
Glycoprotein 90K/Mac-2 BP interacts with galectin-1 and mediates galectin-1 induced cell aggregation
2001-01-01 Tinari, Nicola; Kuwabara, I; Huflejt, Me; Shen, Pf; Iacobelli, Stefano; Liu, Ft
TGF-β-1 increases 90K tumor associated antigen gene expression by increasing upstream regulatory factor binding to the minimal promoter.
2002-01-01 Grassadonia, Antonino; Nakazato, M; Tinari, Nicola; Iurisci, I; Innominato, Pf; Cumashi, A; Piccolo, E; Natoli, Clara; Riccardi, R; Iacobelli, S; LEONARD D., Kohn
Glicomimetici quali potenziali nuovi farmaci per la prevenzione delle metastasi.
2002-01-01 Innominato, Pf; Piccolo, E; Cumashi, A; Grassadonia, Antonino; Iurisci, I; Degidio, M; Tinari, Nicola; Natoli, Clara; Iacobelli, S.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
HCV genotype and serum 90K levels: host and virus related factors predict response to a-ifn therapy | 1995 | Natoli, G; Tinari, Nicola; D'Egidio, Maurizia; Angelucci, Domenico; Artini, Marco; Costanzo, Antonio; Marinelli, Rossana; Balsano, Clara; Levrero, Massimo; Iacobelli, Stefano; Natoli, Clara | |
The 90K tumor associated antigen and clinical progression in human immunodeficiency virus infection | 1995 | Iacobelli, Stefano; Ullrich, A; Tinari, Nicola; Ortona, L; Tamburrini, E; D'Egidio, Maurizia; Ghinelli, F; Sighinolfi, L; Piazza, M; Chirianni, A; Guerra, L; Natoli, Clara | |
A Flow cytometric study of early gastric cancer | 1996 | Ranaldi, R; Santinelli, A; Fabris, G; Mannello, B; Natoli, Clara; Tinari, Nicola; Bearzi, I. | |
Prognostic value of a novel interferon-inducible 90K tumor antigen | 1996 | D'Ostilio, N; Natoli, Clara; Grassadonia, Antonino; Rossi, N; DI STEFANO, P; Amatetti, C; Tinari, Nicola; Iacobelli, S. | |
Prognostic value of a novel interferon-inducible 90K tumor antigen | 1996 | D'Ostilio, N; Natoli, Clara; Grassadonia, Antonino; Rossi, N; Di Stefano, P; Amatetti, C; Tinari, Nicola; Iacobelli, Stefano | |
Elevated serum levels of 90K/MAC-2BP predict unresponsiveness to alfa-interferon therapy in chronic HCV hepatitis patients | 1996 | Artini, M; Natoli, Clara; Tinari, Nicola; Costanzo, A; Marinelli, R; Balsano, C; Porcari, P; Angelucci, D; D'Egidio, Maurizia; Levrero, M; Iacobelli, Stefano | |
Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90k monoclonal antibodies | 1997 | Tinari, Nicola; D'Egidio, Maurizia; Starling, Gary; Seachord, Carrie; Darveau, Richard; Aruffo, Alejandro; Bowen, Michael; Iacobelli, Stefano | |
A PHASE II STUDY OF NEOADJUVANT CHEMOTHERAPY WITH CISTAPLIN, EPIRUBICIN AND VP – 16 FOR STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER | 1998 | Iacobelli, Stefano; L., Irtelli; Sacco, Rocco; T., Martino; Mascitelli, Elia; L., Basilico; M. T., Scognamiglio; Natoli, Clara; O., Fusco; Tinari, Nicola; V., Beltrami | |
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10^6 cells/L | 1998 | Tinari, Nicola; Natoli, Clara; D'Ostilio, N.; Ghinell, F.; Sighinolfi, L. | |
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections | 1999 | Fornarini, B.; Iacobelli, Stefano; Tinari, Nicola; Natoli, Clara; DE MARTINO, M. | |
Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo. | 2000 | B., Fornarini; C., D’Ambrosio; Natoli, Clara; Tinari, Nicola; Iacobelli, Stefano | |
galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis | 2000 | Matarrese, P; Tinari, Nicola; Semeraro, Ml; Natoli, Clara; Iacobelli, Stefano; Malorni, W. | |
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer. | 2000 | Natoli, Clara; Scognamiglio, M. T.; Martino, M. T.; Irtelli, L.; DE TURSI, Michele; Cianchetti, Ettore; Mascitelli, Elia; Tinari, Nicola; Iacobelli, Stefano | |
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties | 2000 | Matarrese, P.; Fusco, O.; Tinari, Nicola; Natoli, Clara; Liu, F. T.; Semeraro, Ml; Malorni, W; Iacobelli, Stefano | |
Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients | 2000 | Iurisci, Ida; Tinari, Nicola; Natoli, Clara; Angelucci, D.; Cianchetti, Ettore; Iacobelli, Stefano | |
Gli analoghi sintetici delle glicoamine come potenziali nuovi farmaci nella prevenzione delle metastasi | 2001 | Innominato, Pf; Natoli, Clara; Tinari, Nicola; Piccolo, E; Grassadonia, Antonino; Iurisci, I; Cumashi, A; Iacobelli, S. | |
Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly | 2001 | Iacobelli, Stefano; Irtelli, L; Martino, Mt; Natoli, Clara; Tinari, Nicola; Grassadonia, Antonino; Rocco, Sacco | |
Glycoprotein 90K/Mac-2 BP interacts with galectin-1 and mediates galectin-1 induced cell aggregation | 2001 | Tinari, Nicola; Kuwabara, I; Huflejt, Me; Shen, Pf; Iacobelli, Stefano; Liu, Ft | |
TGF-β-1 increases 90K tumor associated antigen gene expression by increasing upstream regulatory factor binding to the minimal promoter. | 2002 | Grassadonia, Antonino; Nakazato, M; Tinari, Nicola; Iurisci, I; Innominato, Pf; Cumashi, A; Piccolo, E; Natoli, Clara; Riccardi, R; Iacobelli, S; LEONARD D., Kohn | |
Glicomimetici quali potenziali nuovi farmaci per la prevenzione delle metastasi. | 2002 | Innominato, Pf; Piccolo, E; Cumashi, A; Grassadonia, Antonino; Iurisci, I; Degidio, M; Tinari, Nicola; Natoli, Clara; Iacobelli, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile